Vanda Pharmaceuticals
VNDA
#7960
Rank
NZ$0.65 B
Marketcap
NZ$10.92
Share price
0.32%
Change (1 day)
34.14%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$19.12 Million

According to Vanda Pharmaceuticals's latest financial reports the company's total debt is NZ$19.12 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Vanda Pharmaceuticals - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$21.91 M47.38%
2023-12-31NZ$14.87 M-15.26%
2022-12-31NZ$17.54 M-3.07%
2021-12-31NZ$18.1 M-4.05%
2020-12-31NZ$18.86 M-12.98%
2019-12-31NZ$21.68 M
2018-12-31N/A
2005-12-31NZ$0.2 M-59.44%
2004-12-31NZ$0.51 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$96.36 B 503,674.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$82.36 B 430,481.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$111.68 B 583,775.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$76.00 B 397,243.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$86.07 B 449,895.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$81.36 B 425,259.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA